Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 39 - General protective or antinoxious agents
Patents for A61P 39 - General protective or antinoxious agents (19,019)
09/2003
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003CA2477973A1 Methods for alzheimer's disease treatment and cognitive enhancement
09/17/2003EP1344516A1 Antioxidative composition
09/17/2003EP1343895A2 Streptococcus pyogenes antigens and corresponding dna fragments
09/17/2003EP0657520B9 Antioxidant
09/17/2003CN1443197A Acid-modified arabinogalactan protein composition
09/17/2003CN1443158A Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
09/17/2003CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities
09/16/2003US6620782 compounds having Formula I are potent inhibitors of caspases and apoptotic cell death. Therefore, the inhibitors of this invention can retard or block cell death in a variety of clinical conditions in which the loss of cells, tissues or
09/12/2003WO2003073870A1 Health foods having antiallergic effect
09/12/2003WO2003073869A1 Dietary and cosmetic composition based on crosslinked natural polymers immobilizing active principles
09/12/2003WO2003037268A3 Hepta-, octa- and nonapeptides having antiangiogenic activity
09/12/2003WO2002040486A3 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS
09/12/2003WO2002028362A3 Vaccine composition and stabilisation method
09/11/2003US20030171435 New amphetamine derivatives, antibodies against them and pharmaceutical compositions containing them
09/11/2003US20030171404 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
09/11/2003US20030171392 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
09/11/2003US20030171356 Methods for alzheimer's disease treatment and cognitive enhancement
09/11/2003US20030171337 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and
09/11/2003US20030171267 Albumin fusion proteins
09/11/2003US20030170280 Particles comprising porous and/ or polycrystalline silicon or multilayer porous silicon oxide mirrors; sunscreen agents
09/10/2003EP1342474A1 The use of proline, poly-proline peptides and proline-rich proteins to quench reactive oxygen species
09/10/2003EP1341770A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
09/10/2003CN1441803A Indoloquinazolinones
09/10/2003CN1441770A Modified forms of pharmacologically active agents and uses therefor
09/10/2003CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors
09/09/2003US6617452 Liquid-liquid extraction being carried out in the first stage at a pH-value of about 4; treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence.
09/09/2003CA2239498C Bioartificial devices and cellular matrices therefor
09/04/2003WO2003072802A2 Carboxyfullerenes and methods of use thereof
09/04/2003WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
09/04/2003WO2003072550A1 Novel fused ring indazole compounds
09/04/2003WO2003072105A1 Treatment of effect of chemicals with their ultradilute stereoisomers
09/04/2003WO2003064472A3 Treatment of ms with goat serum
09/04/2003WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
09/04/2003WO2003051805A3 Substituted phenyl naphthalenes as estrogenic agents
09/04/2003US20030166630 Amino acid derivatives and their use as medicines
09/04/2003US20030166613 A macrocyclic diterpene plant extract for treating viral infections; A computer program product for storing the library information of candidate compounds
09/04/2003US20030166511 Cardioprotective composition comprising ceruloplasmin and uses thereof
09/04/2003US20030165569 Composition for topical substance delivery
09/04/2003US20030165514 Modulate immunology response
09/04/2003CA2505984A1 Treatment of effect of chemicals with their ultradilute stereoisomers
09/04/2003CA2476782A1 Carboxyfullerenes and methods of use thereof
09/03/2003EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
09/03/2003EP1339427A2 Method of producing biospecific molecules by protein trans-splicing
09/03/2003EP1339412A1 Formulation containing phosphate derivatives of electron transfer agents
09/03/2003EP1339394A1 Method and preparation for binding acetaldehyde in saliva, stomach and large intestine
09/03/2003EP1019021B1 Stabilized preparations for use in metered dose inhalers
09/03/2003CN1440405A Sulfonyl-pyrrolidine derivatives useful for treatment of neurological disorders
08/2003
08/28/2003WO2003070235A1 Medicinal compositions for inhibiting tryptase
08/28/2003WO2003070188A2 Method of treating trx mediated diseases
08/28/2003US20030162837 Carboxyfullerenes and methods of use thereof
08/28/2003US20030162811 Heterocyclic amines such as 4-(3'-Thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
08/28/2003US20030162789 4-alkylpiperazine substituted phenol derivative or 4-alkylamide substituted phenols for treating neurodegerative diseases such as aging, cancer, diabetes, ischemic stroke, Parkinson's disease, dementia and Huntinton's disease
08/28/2003US20030162701 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them
08/28/2003US20030162196 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders
08/28/2003US20030161863 Administering mixtures of nutrients for prophylaxis of muscular, metabolic or respiratory disorders, injuries, inflammation and/or to relieve stress
08/28/2003CA2476434A1 Method of treating trx mediated diseases
08/27/2003EP1338307A1 Chemical and biological decontamination material and system
08/27/2003EP1161228B1 Composition comprising isoquercetin and ascorbic acid in a sustained release form
08/27/2003EP0901469B1 Arylalkylpiperazine compounds as antioxidants
08/27/2003CN1439004A Indole derivatives useful for treatment of CNS-disorders
08/27/2003CN1438885A Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
08/27/2003CN1438033A Composite medicine for emergency treatment of acute naphthalene poisoning
08/27/2003CN1438029A Composite medicine for emergency treatment of acute poisouing by Tetramine
08/27/2003CN1119291C Method of production of medical electrolysed water and dialysis apparatus using water asdialysis liquid
08/27/2003CN1119168C Health-care drink for delaying senility
08/26/2003US6610820 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
08/26/2003US6610737 Non-psychotropic cannabinoids
08/26/2003US6610690 Administering optically pure (S,S) enantiomer of reboxetine
08/26/2003US6610334 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins
08/26/2003US6610320 Mixture of cocoa plant extract and antichloesterol agent
08/21/2003WO2003068970A1 Sodium-independent transporter carrying acidic amino acid and its gene
08/21/2003WO2003068946A1 Phenalenone derivatives, method for the production thereof and use of the same
08/21/2003WO2003068747A1 Nicotinamide derivates useful as p38 inhibitors
08/21/2003WO2003068234A1 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of e.g. inflammatory, allergic and respiratory diseases
08/21/2003WO2003068232A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003WO2003068228A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003WO2003068197A1 Method for systemic drug delivery through the nail
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003007930A3 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
08/21/2003WO2002064748A3 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2003WO2002036162A3 Compositions for treatment of ocular neovascularization and neural injury
08/21/2003US20030158469 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug
08/21/2003US20030158239 Reacting a selenourea and an alpha-haloacyl halide in a solvent and in the presence of a catalyst; useful as raw materials for drugs and agricultural chemicals
08/21/2003US20030158204 Diamino phenothiazine derivatives and composition comprising same
08/21/2003US20030158122 For treatment of hyperlipidemia and blood coagulation disorders and to reduce levels of virus, bacteria, and endotoxins in blood stream
08/21/2003US20030157225 Food product and process
08/21/2003US20030157191 Administering to a subject undergoing chemotherapy an amount of a chemoprotectant
08/21/2003CA2476618A1 Phenalenone derivatives, method for the production thereof and use of the same
08/21/2003CA2475708A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003CA2475703A1 Aryl ureas with angiogenesis inhibiting activity
08/20/2003EP1336410A1 Protein injection preparations
08/20/2003EP0865288B1 Bioartificial devices and cellular matrices therefor
08/20/2003CN1437475A Combined cartilage and plant extract composition
08/20/2003CN1437470A COX-2 inhibitors and the preventionof the side effects of radiation therapy
08/20/2003CN1436529A Medicine prepn for treating gastrointestial tract reaction caused by chemotherapy
08/20/2003CN1118287C Health-care medicine
08/19/2003US6608106 Contacting the cell with an amount of dehydroascorbic acid effective to increase the concentration of ascorbic acid in the cell
08/19/2003US6607752 Forming a nicotine/cation exchange resin solvent mixture by blending nicotine, resin and solvent together, maintaining the solvnet in liquid state for a second by controlling pressure and temperature, then evaporation the solvent
1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 191